The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Amber Koehler has participated in advisory boards for AbbVie, Janssen, and AstraZeneca. Josie Montegaard has participated in advisory boards for AbbVie and Beigene.
Learning Objectives:
List currently recommended agents for frontline therapy in chronic lymphocytic leukemia (CLL)
Outline key patient characteristics that may help in choice of frontline therapy for treatment-naive CLL
Consider patient and lifestyle factors when selecting a treatment course
Develop a management plan for common adverse events that may occur in patients with CLL on frontline therapy
Speaker(s):
Amber
Koehler,
Physician Assistant, Assistant Professor of Medicine,
Mayo Clinic
Josie
Montegaard,
Lymphoma Nurse Practitioner,
Dana-Farber Cancer Institute
You must be logged in and own this session in order to
post comments.